Good
Partially Aligned
Patient Risk:
Medium
Summary
The claims broadly align with CALDOLOR labeling for major boxed-warning topics (serious cardiovascular thrombotic events and serious GI bleeding/ulceration/perforation), but they include several additional or generalized statements not supported by the provided label excerpts (e.g., specific comparative safety vs acetaminophen, and detailed adverse-effect lists not present in the excerpts).
Category Scores
Accurate Statements
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID).
No specific excerpt provided, but CALDOLOR labeling excerpts explicitly refer to ibuprofen as an NSAID in boxed warning and warnings sections.
The lowest effective dose for the shortest time is recommended for ibuprofen.
Section 2.1: “Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.”
Ibuprofen increases the risk of serious cardiovascular thrombotic events (e.g., myocardial infarction and stroke).
BOXED WARNING and Section 5.1: “NSAIDs cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal.”
Ibuprofen increases the risk of serious gastrointestinal events (e.g., bleeding/ulceration/perforation).
BOXED WARNING and Section 5.2: “NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation…”
Elderly patients are at greater risk for serious gastrointestinal events.
BOXED WARNING: “Elderly patients are at greater risk for serious gastrointestinal events.” and Section 8.5.
Ibuprofen (CALDOLOR) has a risk of serious cardiovascular and gastrointestinal events.
BOXED WARNING; Sections 5.1 and 5.2; Section 8.5 (elderly higher risk).
Unsupported Statements
Common side effects of ibuprofen can include heartburn, nausea, dizziness.
The provided label excerpts do not list these as common side effects.
Ibuprofen can strain the kidneys.
Provided excerpts focus on CV and GI risk; renal risk is not supported by the supplied text (beyond general mention of “renal adverse reactions” in Section 8.5 without describing this specific claim as a prominent adverse effect).
Ibuprofen can raise blood pressure in some people.
Not supported by the provided excerpts.
Ibuprofen may be riskier or may require clinician guidance for people with uncontrolled high blood pressure or certain heart conditions.
Not supported by the provided excerpts.
Ibuprofen may be riskier or may require clinician guidance for people with NSAID-related allergy or asthma flare-ups.
The provided excerpts include a contraindication for a history of asthma/urticaria/allergic reactions after aspirin/other NSAIDs (Section 4), but the statement frames this as “may be riskier or may require clinician guidance,” which is not directly supported by the excerpted wording.
Ibuprofen is an NSAID associated with higher GI and kidney risk compared with acetaminophen.
No acetaminophen comparative safety statements are included in the provided excerpts.
Acetaminophen is not an NSAID.
Not supported by the provided excerpts (and is outside the provided CALDOLOR labeling text).
Acetaminophen has less GI risk for many people.
Not supported by the provided excerpts.
Dosing of acetaminophen must be careful to avoid liver damage.
Not supported by the provided excerpts.
Taking ibuprofen with food if it upsets the stomach is recommended.
No such food/titration guidance is present in the provided excerpts.
Avoid doubling up with other NSAIDs (like naproxen or diclofenac) unless a clinician tells you to.
Not supported by the provided excerpts.
Avoid taking ibuprofen alongside other NSAIDs.
Not supported by the provided excerpts.
Certain blood pressure medications may have reduced effect when taken with ibuprofen.
Not supported by the provided excerpts.
Steroids or some antidepressants can increase the GI bleeding risk when taken with ibuprofen.
Not supported by the provided excerpts.
Taking too much ibuprofen can cause effects on breathing or the heart.
Not supported by the provided excerpts.
Taking ibuprofen with blood thinners increases bleeding risk.
The provided excerpts support increased bleeding risk with anticoagulants (e.g., warfarin) via synergistic effect, but do not broadly support “blood thinners” as an umbrella without specifying those agents from the label excerpt.
Contradictions
Important Omissions
For CALDOLOR, the boxed warning is specifically about serious cardiovascular thrombotic events and serious GI adverse events occurring at any time (with/without warning symptoms), and identifies higher-risk groups (elderly; prior peptic ulcer disease and/or GI bleeding). The AI claims selectively mention GI bleeding/ulcers and does not clearly capture the label’s broader characterization (bleeding/ulceration/perforation) and the “any time, with or without warning symptoms” aspect in the provided claim set.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
Several statements about general adverse effects and specific comparative risks/interactions are not supported by the provided label excerpts. The core boxed-warning concepts (serious CV thrombotic and serious GI bleeding/ulceration/perforation risk) align well, but unsupported or over-generalized claims could misinform risk counseling.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Many safety/dosing/supporting details are either not present in the supplied CALDOLOR label excerpts or are framed more broadly/comparatively than the excerpts support.
Suggested Improvement
Limit claims to what is explicitly supported in the provided labeling excerpts (boxed warning and Sections 2.1, 5.1, 5.2, 7 anticoagulant/aspirin interaction excerpts, and 8.5 geriatric risk) and avoid unsupported lists of “common side effects” or comparative statements involving acetaminophen/other drug classes unless present in the provided label text.